• calendar
  • globeHeston Hyde Hotel, Hounslow, London, UK

March 23-24, 2020

ABOUT CONFERENCE

ABOUT CONFERENCE
  • About Conference.
                We proudly invite all the participants, sponsors and delegates to participate at the welcome you and appreciate your participation at the " World Congress on Cardiovascular Diseases " which will be held during March 23-24, 2020 in London, UK and will be organized around the theme of " Research innovations in cardiovascular diseases ’’ will be operated by experts in the field of Cardiology. This conference will lay a platform for scientists, world-class professors, and cardiologists to discuss an approach for cardiovascular diseases. International Cardiology Conferences is designed to provide diverse and current education that will keep medical professionals alongside of the issues affecting the diagnosis, treatment of Cardiac disorders and prevention. The aim of the conference is to gather the world class experts both from Academic and Industry in a common platform at Cardiology- 2020 Conferences to share their recent research finding to the world and enlighten other esteemed delegates on latest trends in the field of Cardiology. The field incorporates therapeutic analysis and treatment of coronary vein infection, Cardiac imperfections, valvular coronary illness, heart disappointment and electrophysiology. We cordially invite all concerned people from different countries of Europe (UK, London, Spain, Istanbul, Denmark, Netherlands, Germany, France, Italy, Brazil, Turkey, Israel, India, China, and Japan) to join us at our event and make it successful by your presence. Business networking is an platform for vendors to have network and B2B meetings with “Top scientists and colleagues” and with an effectively low cost marketing method for the development of sales and provide wide range of opportunities, based on referrals and introductions either face-to-face at meetings and gatherings, or by other contact methods such as Telephone, E mail, Digital and Increasingly social and business networking websites. 
    Why to attend? 
                   This event acts as great platform to exchange knowledge and get updated to recent researches in respective field. This event will provide an opportunity to build and expand your network with various people and gives chance to make collaboration with other universities and research labs. It also helps you to meet the experts in the relevant field of study. This conference plays a major role in your business development and maximizes the profit. The aim of the conference is to provide the professionals and academicians from various branches to debate and deliberate on social change that is encompassed by innovation and technology. The Cardiovascular conference interrelates with members across the globe focused on learning about Cardiovascular Medicine and Cardiac Surgery and its specialties. This is the sole best opportunity to reach the major participants. Sharing the knowledge and demonstrations, information and B2B meetings with industrialists and potential clients to make a splash with innovative products live and brand recognition at this event. World prominent speakers, the most recent techniques, and the cutting-edge updates in Cardiovascular Medicine and Cardiac Surgery are hallmarks of this conference. Cardiovascular diseases-2020 will join world-class teachers, scientists, Surgeons and cardiologists to discuss methodology for ailment remediation for heart, Thoracic region, Electrocardiography, Heart Failure, Nuclear Cardiology and stroke. 
    Target Audience 
    • Directors, CEO’s of Organizations 
    • Cardiac Surgeons 
    • Physicians 
    • Noble laureates in Health Care and Medicine 
    • Cardiac Nurses & Nurse Practitioners 
    • Cardiology Associations and Societies 
    • Business Professionals 
    • Doctors 
    • Vascular Surgeons 
    • Medical colleges and universities 
    • Professors 
    • Emergency doctors. 
    • Cardio-oncologists. 
    • Anesthesiologists 
    • Medicine Experts 
    • Manufacturing Medical Devices Companies 
    • PhD Scholars 
    For Universities, Associations & Societies: 
    • Association Partnering 
    • Collaboration proposals 
    • Academic Partnering 
    • Group Participation. 
    For Students & Research Scholars: 
    Poster Competition (Winner will get Best Poster Award) 
    • Young Researcher Forum (YRF Award to the best presenter) 
    • Student Attendee 
    • Group registrations 
    For Business Delegates: 
    • Speaker Presentations 
    • Symposium hosting 
    • Book Launch event 
    • Audience participation 
    For Companies: 
    • Exhibitor and Vendor booths 
    • Sponsorship opportunities 
    • Product launch 
    • Scientific Partnering 
    • Marketing and Networking with clients 
    Scientific sessions:
    Track 01: Heart physiology: 
            Cardiovascular system starts with the heart, as heart is major organ in this system. The function of heart determines the functional status of the body. Any physical or functional abnormalities in heart leads to decrease in heart function. So, to know physiology of heart is important. It is the pumping organ which supplies oxygen and nutrients throughout the body constantly, never pausing. Powered by muscles and perfectly synchronized by electrical signals, it's one of nature's finest feats of engineering. SA node acts as natural pacemaker that regulates the heart rhythm. 
    Related societies: The American Society for Preventive Cardiology; American Society of Nuclear Cardiology; American Heart Association; ACC; American Stroke Association; Society for Cardiovascular Angiography and Interventions. 
    Track 02: Cardiovascular diseases: 
              Cardiovascular diseases (CVDs) are the events that are associated with any alteration in the functioning of heart and blood vessels and they include: 
    • coronary heart disease 
    • peripheral arterial disease 
    • rheumatic heart 
    • congenital heart disease 
    • deep vein thrombosis and pulmonary embolism.
    Heart attacks and strokes are acute events and are most commonly caused by a blockage that prevents blood from flowing to the heart or to the brain. 
    Related societies: European Society of Cardiology; British Cardiovascular Society; World Heart Federation, Asian Pacific Society of Cardiology; Cardiac Society of Australia & New Zealand; Russian Society of Cardiology. 
    Track 03: Risk factors: 
              There are many risk factors for cardiovascular heart diseases. Some of the risk factors cannot be avoided which may include age, gender, family history, genetic alterations, being post-menopausal. While some can be controllable are smoking, social habits, obesity, diet, stress and anger. 
    Related societies: The World Society of Cardiovascular & Thoracic Surgeons;; Australian Cardiovascular Health and Rehabilitation Association; Association of Thoracic and Cardiovascular Surgeons of Asia; Chinese Society of Cardiology; The Pan-African Society of Cardiology (PASCAR). 
    Track 04: Hypertension: 
                Hypertension is also called as high blood pressure. Blood pressure is the force with the blood exerts against the blood vessel walls. Hypertension is the primary cause that leads to various cardiovascular diseases. It can stay asymptomatic for years, but the damage to blood vessels and heart continues to occur. Modifiable risk factors include unhealthy diets (excessive salt consumption, a diet high in saturated fat and trans fats, low intake of fruits and vegetables), physical inactivity, consumption of tobacco and alcohol, and being overweight or obese. Non-modifiable risk factors includes a family history of hypertension, age over 65 years and co-existing diseases such as diabetes or kidney disease. 
    Related societies: Asian Pacific Society of Hypertension; Association of Cardiologists of Kazakhstan, The Heart foundation of Malaysia; The Japanese Society of Hypertension, ; British Hypertension Society. 
    Track 05: Arrhythmias: 
                 Abnormal rate or rhythm of heart is called arrhythmias. Arrhythmias may be slow (bradycardia), fast (tachycardia), irregular heartbeat (flutter or fibrillation), early heartbeat (premature contraction).Arrhythmias occurs when the heart's natural pacemaker develops an abnormal rate or rhythm or when the normal conduction pathway is disturbed or when another part of the heart takes over as pacemaker. Nearly everyone experiences arrhythmia at least once, but not all the conditions are problematic. When the arrhythmia s interfere with blood flow, it may cause damage to brain, lungs and other vital organs also. So, arrhythmias are to be treated in early stages of detection. 
    Related societies: Association of Pediatric Cardiology; Cardiological Society of India; Asian Society of Cardiovascular Imaging; British Junior Cardiologists Association; Croatian Cardiac Society; European Cardiology Congress, American Society of Hypertension; Brazilian Society of Hypertension.  
    Track 06: Angina: 
              Angina is discomfort or chest pain which occurs when the heart muscle doesn’t get sufficient oxygen rich blood supply. It is generally not a disorder or disease, but a symptom in the development of coronary artery disease. It is described as squeezing, pressure or heaviness in heart. Various types of angina includes stable angina, unstable angina, and prinzmetal (variant) angina. Treatment includes various drug and lifestyle changes. 
    Related societies: Association of Black Cardiologists; Algerian Society of Hypertension; Interventional Cardiovascular Society of Malaysia; Israeli Cardiology and Critical Care Nursing Society; Japanese Society of Thoracic Radiology; Korean Society for Thoracic and Cardiovascular Surgery; Kyrgyz Society of Cardiology; Lebanese Society of Cardiology 
    Track 07: Atherosclerosis: 
              Atherosclerosis is defined as the narrowing of blood vessels due to deposition of plaques in the artery. Atherosclerosis does not show any symptoms until it severely narrows the arteries or completely narrows the artery. Age, obese, lack of exercise, high fat diet are some of the reasons for atherosclerosis. It leads to coronary artery disease where the artery that supplies blood to heart gets stiffened and narrowed due to deposition of plaque. 
    Related societies: Canadian Cardiovascular Society; Argentine Society of Cardiology; ; Association of Cardiologists of Bosnia & Herzegovina; British Heart Foundation; Spanish Heart Foundation. 
    Track 08: Congestive heart failure (CHF): 
             CHF is also called as Heart Failure. It occurs when the heart muscle loses its ability to pump the blood too sufficiently. Not all the conditions that leads to heart failure can be reversible, but signs and symptoms can be improved. Shortness of breath, fatigue, weakness, reduced ability to exercise, are some of the symptoms. Types include Left Ventricular heart failure, Right ventricular heart failure, systolic heart failure, diastolic heart failure. 
    Related societies: Brazilian Society of Cardiology; Heart Failure Society of America; The Japanese Heart Failure Society; Japanese Society of Echocardiography; ; British Heart Failure Society. 
    Track 09: Venous thromboembolism: (VTE): 
                 Venous thromboembolism generally refers to clot in the vein. VTE includes deep vein thrombosis and pulmonary embolism. A deep vein thrombosis (DVT) occurs when a blood clot occurs in a deep vein, usually in the lower leg, thigh, or pelvis. When a clot breaks loose and travels through the bloodstream to the lungs, Pulmonary Embolism is formed. DVT is associated with swelling of legs and pulmonary embolism is associated with shortness of breath and chest pain. DVT is treated with anticoagulants and other drugs based on the condition and complication. 
    Related societies: Austrian Heart Foundation; Belorussian Scientific Society of Cardiologists; Belgian Society of Cardiology; Spanish Society of Cardiology; British Cardiac Society. 
    Track 10: Myocardial Infarction: 
                  Myocardial infarction is also called as “Heart Attack”. It occurs when the blood supply to heart muscle is abruptly stopped causing tissue damage. Blood supply is stopped due to many reasons and one of them is deposition of fat, cholesterol etc. Risk factors includes high cholesterol, obesity, smoking, age, and family history. MI causes tightness in chest, shortness of breath. 
    Related societies: International Academy of Cardiology; British Heart Foundation; European Society of Cardiology; British cardiology society; Luxembourg Society of Cardiology.   
    Track 11: Cardiomyopathies: 
               Cardiomyopathy is the condition in which the heart muscle that makes it harder for heart to pump blood to the rest of body. Cardiomyopathy can lead to heart failure. Restricted, hypertrophic, dilated are the types of cardiomyopathies. This track gives information regarding the type of cardiomyopathies and the treatment used. 
    Related societies: The American Society for Preventive Cardiology; American Society of Nuclear Cardiology; American Heart Association; ACC; American Stroke Association; Society for Cardiovascular Angiography and Interventions. 
    Track 12: Cardiac toxicity: 
                   Cardio toxicity is damage to heart due to harmful chemicals that are given in the treatment of cancer. Radiation and chemotherapy causes damage to either physiology or anatomy of heart. Apart from causing cell death, various cardiac toxicity caused are cardiomyopathy, myocarditis, pericarditis, acute coronary syndrome, congestive heart failure. 
    Related societies: European Society of Cardiology; British Cardiovascular Society; World Heart Federation, Asian Pacific Society of Cardiology; Cardiac Society of Australia & New Zealand; Russian Society of Cardiology. 
    Track 13: Cardiac diagnosis test: 
                  The cardiac diagnostic tests are techniques used for determining the heart conditions by using sound versus unfortunate, pathologic, heart capacity. Various invasive and noninvasive tests are available to depict cardiovascular structure and capacity. 
    • Electrocardiogram (ECG). 
    • Transthoracic echocardiogram (echo or TTE). 
    • Trans esophageal echocardiogram (TEE). 
    • Positron emission tomography (PET) scan 
    • PET F-18 FDG (fluorodeoxyglucose) scan 
    • Thallium scans or myocardial perfusion scans. 
    • MUGA scans/radionuclide angiography (RNA) scans. 
    • Holter monitor. 
    • Event recorder. 
    • Implantable loop recorder.
    • Tilt table test. 
    • Electrophysiology study.
    • Cardiac catheterization (coronary angiogram). MRI of the heart. 
    Magnetic resonance angiography (MRA) of the heart. 
    • Cardiac CT scan. 
    • Nuclear cardiology. 
    • ECHO cardiogram. 
    Related societies: The World Society of Cardiovascular & Thoracic Surgeons; Australian Cardiovascular Health and Rehabilitation Association; Association of Thoracic and Cardiovascular Surgeons of Asia; Chinese Society of Cardiology; The Pan-African Society of Cardiology (PASCAR). 
    Track 14: Prevention and lifestyle changes: 
                        Prevention is always a best than cure. In case of cardiovascular disorders, if not controlled or prevented it may lead to severe complications and adverse conditions. So cardio diseases can be prevented by various measures like avoid smoking, regular exercise, diet management, limit alcohol consumption, stress management, limit fatty food, etc. 
    Related societies: British Association for Cardiovascular Prevention and Rehabilitation; World Heart Failure Society; Austrian Heart Foundation; Austrian Society of Cardiology; Philippine Heart Association. 
    Track 15: Novel drug development systems: 
                  The application of genomic technologies, along with systems biology approaches, identified multiple potential new cardiovascular drug targets and actual molecules with potential cardiovascular applications. 
    Related societies: Asian Pacific Society of Hypertension; Association of Cardiologists of Kazakhstan, The Heart foundation of Malaysia; The Japanese Society of Hypertension; British Hypertension Society. 
    Track 16: Surgical and interventional cardiology: 
    • Adult congenital heart surgery 
    • Angioplasty and stenting 
    • Aortic and thoracic endografts 
    • Carotid artery stenting, carotid endarterectomy, and atherectomy 
    • Complex lower extremity revascularization (also known as limb salvage) 
    • Coronary artery bypass graft (CABG) surgery, including traditional surgery, robotic minimally invasive direct coronary artery bypass (MIDCAB), and Thoracoscopic CABG 
    • Endovascular aortic reconstruction 
    • Heart valve repair and replacement, including Transcatheter Aortic Valve Replacement (TAVR) and mitral valve repair and replacement, minimally invasive aortic valve replacement, port access mitral valve repair, and robotic approaches 
    • Thoracic aortic surgery and thoracic endovascular aortic surgery which includes an aortic aneurysm, aortic dissection, and traumatic aortic rupture. 
    • Peripheral vascular interventions includes bypass surgery and peripheral angioplasty and stenting 
    • Thoracic surgery for lung cancers, esophageals cancer, chest injury repair, and radiofrequency ablation of lung cancers 
    • Thrombectomy 
    • Varicose vein treatments, including radiofrequency ablation (RFA), endovenous laser therapy (EVLT), sclerotherapy, foam sclerotherapy, and vein stripping 
    • Device implantation 
    Related societies: Canadian Association of Cardiovascular Prevention and Rehabilitation; Elsevier Society Partners in Cardiology; American Society for Preventive Cardiology; American Society of Echocardiography; Canadian Association of Interventional Cardiology. 
    Track 17: Molecular cardiology: 
                    Molecular cardiology is fast growing area which focus on the application of molecular biological techniques for investigation, diagnosis, prevention and treatment. For the development of gene therapy and stem cell therapy for heart diseases, molecular cardiology is important to know. 
    Related societies: Association of Black Cardiologists; Algerian Society of Hypertension; Interventional Cardiovascular Society of Malaysia; Israeli Cardiology and Critical Care Nursing Society; Japanese Society of Thoracic Radiology; Korean Society for Thoracic and Cardiovascular Surgery; Kyrgyz Society of Cardiology; Lebanese Society of Cardiology 
    Track 18: Cardio oncology: 
                  Cardio oncology is characterized as the interdisciplinary field of medication which helps to concentrate on the heart conditions of patients who have been treated for malignant growth. The main aim of this track is to discover a harmony between oncologic viability and decreasing unfavorable cardiovascular impacts. 
    Related societies: Canadian Cardiovascular Society; Argentine Society of Cardiology;  Association of Cardiologists of Bosnia & Herzegovina; British Heart Foundation; Spanish Heart Foundation. 
    Track 19: Sports and exercise cardiology: 
                  It is a multidisciplinary approach for evaluation of cardiac ability and function in athletes. It provides the athletes the maximum support to reach their goals. 
    Related societies: Brazilian Society of Cardiology; Heart Failure Society of America; The Japanese Heart Failure Society; Japanese Society of Echocardiography; British Heart Failure Society. 
    Track 20: Cardiac regeneration: 
          It is defined as regeneration of lost or injured tissues or organs of heart. However large organs like skin and liver loses the ability to regenerate, there is a hope for heart and lung tissues to regenerate. 
    • Tissue graft cardiac cell replacement. 
    • Cardiac remodeling 
    • Cardiac regenerative therapy 
    • Congenital heart disease and regeneration 
    • Heart repair, heart tissue regeneration and stem cells 
    • Biomimetic heart valve replacement 
    • Stem cell-derived engineered cardiac tissue 
    Related societies: Austrian Heart Foundation; Belorussian Scientific Society of Cardiologists; Belgian Society of Cardiology; Spanish Society of Cardiology; British Cardiac Society. 
    Track 21: Drug management in cardiovascular diseases: 
                     Drug treatment is important to control various abnormalities in cardiovascular diseases. They also prevent further complications. Classes of drugs that are used in the treatment of these conditions are: 
    • Anti-hypertensives 
    • Anti-anginal 
    • Cardio tonic drugs 
    • Diuretics 
    • Thrombolytic drugs 
    • Anti-coagulants 
    • Anti-platelets 
    • Vasodilators 
    Related societies: International Academy of Cardiology; British Heart Foundation; European Society of Cardiology; British cardiology society; Luxembourg Society of Cardiology 
    Track 22: Novel innovations in cardiac surgery and treatment: 
                   New innovations in cardiac surgery have great influence on improvement on cardiac function in severe cardiac patients. Some of them includes: 
    Barostim Neo Neuromodulation Device for heart failure:  
                  This device have an effective neuromodulation therapy for advanced heart failure patients who are not indicated for Cardiac Resynchronization Therapy 
    • Adult Human Heart Tissue Grown using Biowire II platform: 
                       Using the Biowire II platform, 3D engineered cardiac tissues were grown and then delivered electrical stimulation to them over long periods of time. This led to the tissues having a phenotype that is more characteristic of the adult myocardium, including not exhibiting spontaneous beating that is one of the tell-tale signs of the fetal phenotype. 
    Carbon Nanotube Fibers as Electrical Bridges for damaged heart tissue: 
                       Biocompatible carbon nanotube fibers are used as electrical bridges that span across damaged heart tissue. 
    • Biomaterial tricks immune system to grow new blood vessels: 
                      New interest has developed in using the body’s own immune system to help aid this process. To this end, the researchers developed unique biomaterials to modulate the local immune system to promote the formation of new blood vessels. 
    Related societies: The American Society for Preventive Cardiology; American Society of Nuclear Cardiology; American Heart Association; ACC; American Stroke Association; Society for Cardiovascular Angiography and Interventions.